Citation

83 FR 6192

Multiple canonical documents share this first-page citation.

Determination of Regulatory Review Period for Purposes of Patent Extension; VASCEPA Tuesday, February 13, 2018 83 FR 6192
Mallinkrodt Pharmaceuticals LLC; Withdrawal of Approval of an Abbreviated New Drug Application for PEMOLINE Tablets, 18.75 Milligrams, 37.5 Milligrams, and 75 Milligrams Tuesday, February 13, 2018 83 FR 6192